|
IL61904A
(en)
*
|
1981-01-13 |
1985-07-31 |
Yeda Res & Dev |
Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
|
|
US4659669A
(en)
*
|
1981-03-02 |
1987-04-21 |
Regents Of The Univ. Of California |
Microbial expression of human influenza hemagglutinin proteins
|
|
US4533254A
(en)
|
1981-04-17 |
1985-08-06 |
Biotechnology Development Corporation |
Apparatus for forming emulsions
|
|
US4625015A
(en)
*
|
1982-08-23 |
1986-11-25 |
Scripps Clinic & Research Foundation |
Broad spectrum influenza antisera
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US4728575A
(en)
|
1984-04-27 |
1988-03-01 |
Vestar, Inc. |
Contrast agents for NMR imaging
|
|
US4752473A
(en)
*
|
1984-10-12 |
1988-06-21 |
The Regents Of The University Of California |
Expression of glycosylated human influenza hemagglutinin proteins
|
|
US4753788A
(en)
|
1985-01-31 |
1988-06-28 |
Vestar Research Inc. |
Method for preparing small vesicles using microemulsification
|
|
IL78775A
(en)
|
1985-05-15 |
1992-06-21 |
Biotech Australia Pty Ltd |
Oral vaccines
|
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
|
US4728578A
(en)
|
1986-08-13 |
1988-03-01 |
The Lubrizol Corporation |
Compositions containing basic metal salts and/or non-Newtonian colloidal disperse systems and vinyl aromatic containing polymers
|
|
ATE108067T1
(de)
|
1986-09-22 |
1994-07-15 |
Univ Emory |
Impfstoff und verfahren zur herstellung.
|
|
NZ219516A
(en)
|
1987-02-10 |
1991-02-26 |
Wellcome Found |
Fusion proteins of hbcag (hepatitis b virus core antigen)
|
|
NZ219515A
(en)
*
|
1987-02-10 |
1989-09-27 |
Wellcome Found |
Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope
|
|
US6130082A
(en)
*
|
1988-05-05 |
2000-10-10 |
American Cyanamid Company |
Recombinant flagellin vaccines
|
|
ATE121782T1
(de)
|
1988-05-05 |
1995-05-15 |
Praxis Biolog Inc |
Rekombinante vakzine von flagellin.
|
|
US4935171A
(en)
|
1989-01-27 |
1990-06-19 |
Vestar, Inc. |
Method for vesicle formation
|
|
US5709879A
(en)
|
1990-06-29 |
1998-01-20 |
Chiron Corporation |
Vaccine compositions containing liposomes
|
|
US5500366A
(en)
*
|
1990-09-18 |
1996-03-19 |
Biotech Australia Pty. Ltd. |
Polynucleotide encoding T-cell epitopes of the protein TraT
|
|
US5290686A
(en)
|
1991-07-31 |
1994-03-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Expression of influenza a M2 protein in baculovirus
|
|
JPH07502646A
(ja)
|
1991-10-21 |
1995-03-23 |
メディミューン，インコーポレーテッド |
リポタンパク質の分泌シグナルをコード化するｄｎａを含む細菌発現ベクター
|
|
US5877289A
(en)
*
|
1992-03-05 |
1999-03-02 |
The Scripps Research Institute |
Tissue factor compositions and ligands for the specific coagulation of vasculature
|
|
IL101639A0
(en)
|
1992-04-17 |
1992-12-30 |
Yeda Res & Dev |
Recombinant influenza vaccines
|
|
FR2695563B1
(fr)
*
|
1992-09-11 |
1994-12-02 |
Pasteur Institut |
Microparticules portant des antigènes et leur utilisation pour l'induction de réponses humorales ou cellulaires.
|
|
US6337070B1
(en)
*
|
1993-04-29 |
2002-01-08 |
Takara Shuzo Co., Ltd. |
Polypeptides for use in generating anti-human influenza virus antibodies
|
|
EP0621339B1
(en)
|
1992-09-17 |
2001-10-24 |
Takara Shuzo Co. Ltd. |
Immunogenic human influenza A virus haemagglutinin polypeptides
|
|
US5464933A
(en)
*
|
1993-06-07 |
1995-11-07 |
Duke University |
Synthetic peptide inhibitors of HIV transmission
|
|
ES2370937T3
(es)
*
|
1993-09-13 |
2011-12-23 |
Protein Sciences Corporation |
Un método para producir vacunas antigripales polivalentes a base de hemaglutinina.
|
|
US5976552A
(en)
*
|
1995-04-28 |
1999-11-02 |
Protein Sciences Corporation |
Virus vaccines
|
|
US5762939A
(en)
*
|
1993-09-13 |
1998-06-09 |
Mg-Pmc, Llc |
Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
|
|
JPH09511381A
(ja)
*
|
1994-01-11 |
1997-11-18 |
ブラームス・インターユニバージテーア・インスティテュート・ボーア・ビーオテクノロジー |
インフルエンザワクチン
|
|
US6764682B1
(en)
*
|
1994-06-16 |
2004-07-20 |
Aventis Pasteur Limited |
Adjuvant compositions containing more than one adjuvant
|
|
US5612037A
(en)
*
|
1994-07-26 |
1997-03-18 |
Connaught Laboratories, Inc. |
Influenza virus subunit conjugates
|
|
US5512294A
(en)
|
1994-08-05 |
1996-04-30 |
Li; King C. |
Targeted polymerized liposome contrast agents
|
|
US6132764A
(en)
|
1994-08-05 |
2000-10-17 |
Targesome, Inc. |
Targeted polymerized liposome diagnostic and treatment agents
|
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
|
FR2723849B1
(fr)
|
1994-08-31 |
1997-04-11 |
Biovector Therapeutics Sa |
Procede pour augmenter l'immunogenicite, produit obtenu et composition pharmaceutique
|
|
CA2218385A1
(en)
|
1995-04-17 |
1996-10-24 |
Pierre Hauser |
Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins
|
|
SE9604322D0
(sv)
|
1996-11-25 |
1996-11-25 |
Astra Ab |
Bacterial antigens and vaccine compositions II
|
|
DK1005368T3
(da)
|
1997-03-10 |
2010-01-04 |
Ottawa Hospital Res Inst |
Anvendelse af nukleinsyrer, der indeholder ikke-metyleret CpG dinukleotid i kombination med alun som hjælpestoffer
|
|
DK0977874T3
(da)
|
1997-04-18 |
2006-03-20 |
Biotechnolog Forschung Gmbh |
Svækket salmonella-stamme anvendt som bæremedium til oral immunisering
|
|
EP1003850B1
(en)
|
1997-06-06 |
2009-05-27 |
The Regents of the University of California |
Inhibitors of dna immunostimulatory sequence activity
|
|
CA2297786C
(en)
*
|
1997-08-05 |
2011-06-14 |
Vlaams Interuniversitair Instituut Voor Biotechnologie |
New immunoprotective influenza antigen and its use in vaccination
|
|
US7731972B1
(en)
*
|
2000-02-04 |
2010-06-08 |
Vlaams Interuniversitair Instituut Voor Biotechnologie |
Immunoprotective influenza antigen and its use in vaccination
|
|
US6169175B1
(en)
|
1997-08-06 |
2001-01-02 |
Centers For Disease Control And Prevention |
Preparation and use of recombinant influenza A virus M2 construct vaccines
|
|
US6060308A
(en)
*
|
1997-09-04 |
2000-05-09 |
Connaught Laboratories Limited |
RNA respiratory syncytial virus vaccines
|
|
EP1027063B1
(en)
|
1997-09-29 |
2009-02-18 |
The Macfarlane Burnet Institute For Medical Research And Public Health Ltd |
Mannose receptor bearing cell line and antigen composition
|
|
US6440736B1
(en)
|
1998-10-16 |
2002-08-27 |
U-Bisys B.V. |
Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules
|
|
US6086881A
(en)
|
1998-05-15 |
2000-07-11 |
Children's Medical Center Corp. |
Spatially aligned conjugated composition having a thioether bond linkage
|
|
TWI229679B
(en)
|
1998-06-20 |
2005-03-21 |
United Biomedical Inc |
Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
|
|
IL127331A0
(en)
*
|
1998-11-30 |
1999-09-22 |
Yeda Res & Dev |
Peptide-based vaccine for influenza
|
|
WO2001040280A2
(en)
|
1999-11-29 |
2001-06-07 |
Inotek Corporation |
Composition and method for treating a microbial infection
|
|
WO2001040274A2
(en)
*
|
1999-12-06 |
2001-06-07 |
Whitehead Institute For Biomedical Research |
Inhibition of hrsv membrane fusion
|
|
AU2001248314B2
(en)
*
|
2000-02-18 |
2004-08-19 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Use of Oprl lipoprotein from pseudomonas as a Th1 inducing natural adjuvant for heterologous antigens
|
|
WO2001092548A2
(en)
*
|
2000-06-01 |
2001-12-06 |
St. Jude Children's Research Hospital |
Vaccine and gene therapy vector and methods of use thereof
|
|
MXPA02012254A
(es)
*
|
2000-06-23 |
2003-04-25 |
American Cyanamid Co |
Montaje de particulas quimericas semejantes al virus de influenza y del tipo silvestre.
|
|
US20020061312A1
(en)
*
|
2000-07-31 |
2002-05-23 |
Ruslan Medzhitov |
Innate immune system-directed vaccines
|
|
CN1549726A
(zh)
|
2000-07-31 |
2004-11-24 |
耶鲁大学 |
先天性免疫系统指导的疫苗
|
|
US20030232055A1
(en)
*
|
2000-07-31 |
2003-12-18 |
Ruslan Medzhitov |
Innate immune system-directed vaccines
|
|
CA2426312C
(en)
*
|
2000-10-18 |
2014-01-14 |
Ralph A. Tripp |
Compositions and methods for modulating rsv infection and immunity
|
|
WO2002042326A1
(en)
*
|
2000-11-22 |
2002-05-30 |
Biota Scientific Management Pty Ltd |
A method of expression and agents identified thereby
|
|
US20030175287A1
(en)
*
|
2001-01-03 |
2003-09-18 |
Yale University |
Innate immune system-directed vaccines
|
|
CA2435000C
(en)
*
|
2001-01-18 |
2014-03-25 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Oligomeric complexes of chimeric proteins with enhanced immunogenic potential
|
|
US8703146B2
(en)
*
|
2001-04-20 |
2014-04-22 |
Institute For Systems Biology |
Toll-like receptor 5 ligands and methods of use
|
|
EP1379552B2
(en)
*
|
2001-04-20 |
2014-11-19 |
The Institute for Systems Biology |
Toll-like receptor 5 ligands and methods of use
|
|
WO2003102165A2
(en)
|
2002-02-21 |
2003-12-11 |
Apovia, Inc. |
IMMUNOGENIC HBc CHIMER PARTICLES STABILIZED WITH AN N-TERMINAL CYSTEINE
|
|
US20030175863A1
(en)
*
|
2001-08-15 |
2003-09-18 |
Birkett Ashley J. |
Influenza immunogen and vaccine
|
|
US7361352B2
(en)
*
|
2001-08-15 |
2008-04-22 |
Acambis, Inc. |
Influenza immunogen and vaccine
|
|
DE60234375D1
(de)
*
|
2001-09-14 |
2009-12-24 |
Cytos Biotechnology Ag |
VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
|
|
AU2002361682A1
(en)
|
2001-12-14 |
2003-06-30 |
Elizabeth Kopp |
Innate immune system-directed vaccines
|
|
US7285289B2
(en)
|
2002-04-12 |
2007-10-23 |
Nagy Jon O |
Nanoparticle vaccines
|
|
EP1597350B1
(en)
|
2003-02-27 |
2015-04-08 |
Yeda Research And Development Co., Ltd. |
Nucleic acid molecules, and compositions containing same useful for treating and detecting influenza virus infection
|
|
KR20050114225A
(ko)
*
|
2003-03-07 |
2005-12-05 |
머크 앤드 캄파니 인코포레이티드 |
인플루엔자 바이러스 백신
|
|
US8592197B2
(en)
*
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
WO2005042564A1
(en)
*
|
2003-10-20 |
2005-05-12 |
Sidney Kimmel Cancer Center |
Flagellin fusion proteins as adjuvants or vaccines and methods of use
|
|
CA2548992A1
(en)
*
|
2003-12-11 |
2005-08-11 |
Vaxdesign Corporation |
Immunotherapy compositions, method of making and method of use thereof
|
|
CA2555253A1
(en)
|
2004-02-06 |
2005-08-25 |
Yale University |
Compositions of pamps and listeria monocytogenes and methods of use
|
|
EP1793850A4
(en)
*
|
2004-09-21 |
2010-06-30 |
Medimmune Inc |
ANTIBODIES TO THE METHOD AND METHOD FOR THE PRODUCTION OF VACCINES AGAINST THE RESPIRATORY SYNCYTIAL VIRUS
|
|
WO2006039701A1
(en)
*
|
2004-10-01 |
2006-04-13 |
University Of South Florida |
Flagellin-based adjuvants and vaccines
|
|
CA2587084C
(en)
*
|
2004-10-08 |
2019-07-16 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Modulation of replicative fitness by using less frequently used synonym ous codons
|
|
DE102004049223A1
(de)
|
2004-10-08 |
2006-04-20 |
Johannes-Gutenberg-Universität Mainz |
Zubereitung zum Impfen, Impfverfahren und Verwendung einer Impf-Zubereitung
|
|
TW200636064A
(en)
*
|
2004-10-28 |
2006-10-16 |
Centocor Inc |
Anti-respiratory syncytial virus antibodies, antigens and uses thereof
|
|
EP1827489B1
(en)
*
|
2004-12-16 |
2012-10-31 |
Wake Forest University Health Sciences |
Use of flagellin in tumor immunotherapy
|
|
US8420102B2
(en)
*
|
2006-03-07 |
2013-04-16 |
Vaxinnate Corporation |
Compositions that include hemagglutinin
|
|
NZ556004A
(en)
|
2004-12-21 |
2010-05-28 |
Vaxinnate Corp |
Compositions of influenza viral proteins comprising at least one flagellin and at least one influenza M2 protein
|
|
US20090162400A1
(en)
*
|
2004-12-21 |
2009-06-25 |
Powell Thomas J |
Compositions of influenza viral proteins and methods of use thereof
|
|
HU227285B1
(en)
*
|
2004-12-29 |
2011-01-28 |
Mta Enzimologiai Intezet |
Modified flagellins and flagellar filaments useful as receptors and processes for producing same
|
|
EP2374474A1
(en)
*
|
2005-01-19 |
2011-10-12 |
Vaxinnate Corporation |
Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response
|
|
WO2006083706A2
(en)
|
2005-01-31 |
2006-08-10 |
Vaxinnate Corporation |
Method to identify polypeptide toll-like receptor (tlr) ligands
|
|
WO2006083792A2
(en)
|
2005-01-31 |
2006-08-10 |
Vaxinnate Corporation |
Novel polypeptide ligands for toll-like receptor 2 (tlr2)
|
|
AR054020A1
(es)
|
2005-03-23 |
2007-05-30 |
Glaxosmithkline Biolog Sa |
Nuevo uso
|
|
JP4976376B2
(ja)
*
|
2005-04-08 |
2012-07-18 |
メディミューン，エルエルシー |
哺乳動物メタニューモウイルスに対する抗体
|
|
AU2006279323B2
(en)
|
2005-08-16 |
2013-08-01 |
Merck Sharp & Dohme Corp. |
Influenza recombinant subunit vaccine
|
|
CU23578A1
(es)
*
|
2005-09-16 |
2010-09-30 |
Ct Ingenieria Genetica Biotech |
Proteína de la cápsida del virus dengue inductora de respuesta protectora y composición vacunal
|
|
US20070111331A1
(en)
*
|
2005-11-16 |
2007-05-17 |
Chin-Yih Rex Hong |
Diagnostic methods using magnetic nanoparticles
|
|
PT1968632E
(pt)
|
2005-12-06 |
2012-07-16 |
Yeda Res & Dev |
Vacina da gripe melhorada
|
|
PL2478916T3
(pl)
|
2006-01-27 |
2020-11-16 |
Seqirus UK Limited |
Szczepionki przeciw grypie zawierające hemaglutyninę i białka macierzy
|
|
JP2009533455A
(ja)
|
2006-04-12 |
2009-09-17 |
マサチューセッツ インスティテュート オブ テクノロジー |
癒着を阻害するための組成物および方法
|
|
USRE46453E1
(en)
*
|
2006-04-19 |
2017-06-27 |
Postech Foundation |
Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer
|
|
WO2007125535A1
(en)
*
|
2006-05-01 |
2007-11-08 |
Biondvax Pharmaceuticals Ltd. |
Recombinant flagellin gene and uses thereof
|
|
JPWO2008010478A1
(ja)
*
|
2006-07-21 |
2009-12-17 |
公立大学法人横浜市立大学 |
フラジェリン変異体ワクチン
|
|
EA017887B1
(ru)
|
2007-08-02 |
2013-03-29 |
Байондвакс Фармасьютикалз Лтд. |
Полимерные мультиэпитопные вакцины против гриппа
|
|
WO2009073133A1
(en)
*
|
2007-11-29 |
2009-06-11 |
Vaxinnate Corporation |
Compositions of toll-like receptor agonists and papillomavirus antigens and uses thereof
|
|
WO2009082440A2
(en)
*
|
2007-12-18 |
2009-07-02 |
Vaxinnate Corporation |
Compositions of toll-like receptor agonists and malaria antigens and methods of use
|
|
AU2009236585B2
(en)
|
2008-04-18 |
2013-03-07 |
Vaxinnate Corporation |
Deletion mutants of flagellin and methods of use
|
|
BRPI0911604A2
(pt)
*
|
2008-04-25 |
2015-12-15 |
Inst Systems Biology |
vacinas de polipeptídeo de flagelina
|
|
JP2013516469A
(ja)
*
|
2010-01-06 |
2013-05-13 |
ヴァクシネイト コーポレイション |
高齢者に保護免疫を提供するための方法及び組成物
|
|
WO2012115715A2
(en)
|
2011-02-21 |
2012-08-30 |
Vaxinnate Corporation |
Compositions with enhanced immunogenicity and/or reduced reactogenicity and methods of use
|
|
EP2681246A4
(en)
|
2011-02-28 |
2015-05-06 |
Vaxinnate Corp |
VACCINE AGAINST DENGUE TATRAVALENT AND MIXED BIVALENT
|
|
EP2773674A4
(en)
|
2011-11-04 |
2015-04-29 |
Vaxinnate Corp |
IMMUNOLOGICAL CONSTRUCTIONS AND ASSOCIATED METHODS
|
|
US8932598B2
(en)
|
2012-08-28 |
2015-01-13 |
Vaxinnate Corporation |
Fusion proteins and methods of use
|